>>/161477/, >>/161478/, >>/161479/, >>/161480/, >>/161481/, >>/161482/, >>/161483/, >>/161484/, >>/161485/, >>/161486/, >>/161487/, >>/161488/, >>/161489/, >>/161490/, >>/161491/, >>/161492/, >>/161493/, >>/161494/, >>/161495/, >>/161496/, >>/161497/, >>/161498/, >>/161499/, >>/161500/, >>/161501/, >>/161502/, >>/161503/, >>/161504/, >>/161505/, >>/161506/, >>/161507/, >>/161508/, >>/161509/, >>/161510/, >>/161511/, >>/161512/, >>/161513/, >>/161514/, >>/161515/
Oilfield Rando @Oilfield_Rando - I truly wonder which of these will be a more significant development:
1. The left learning that the authorities won’t do anything about the left’s terrorism.
2. The right learning that the authorities won’t do anything about the left’s terrorism
Quote
Feni𝕏 Ammunition @FenixAmmunition
Let's say there's another shooting next week, and another next week.
Let's say the frequency increases to two per week after that.
At what point do people start coming up with their own solutions?
https://x.com/Oilfield_Rando/status/1971019245430710607
Oilfield Rando @Oilfield_Rando - Video: They sabotaged his speech so he just beat them to death with a stream of consciousness roasting. What a legend. What a statesman. What an American hero.
Quote
Clash Report @clashreport
Trump:
Years ago, I bid $500 million to rebuild the UN complex, marble floors, mahogany walls, best of everything.
They chose another plan, cost $2–4 billion, far worse, massive overruns, no marble floors. I was right.
>>/23647096/ pb
https://x.com/Oilfield_Rando/status/1970653744120602819
Patrick Holleran @pat11060 - Why DMSO Hasn’t Been Widely Trialed for COPD
Regulatory Skepticism
The FDA approved DMSO only for interstitial cystitis, citing concerns about toxicity, side effects, and lack of reproducible efficacy in other conditions.
Early studies in the 1960s–80s showed mixed results, and without strong pharmaceutical backing, DMSO was sidelined.
No Patent Incentive
DMSO is cheap and unpatentable. That means no financial incentive for pharmaceutical companies to fund large-scale trials.
COPD drugs like mepolizumab and roflumilast are heavily marketed because they’re proprietary.
Medical Orthodoxy
Treatments outside the mainstream especially those with anecdotal support but limited trial data are often dismissed as “fringe.”
Even though many patients report benefits, without randomized controlled trials (RCTs), these claims are rarely taken seriously.
What Would Justify a Trial?
Biological rationale:
DMSO reduces inflammation and scavenges free radicals both central to COPD pathology.
Patient-reported outcomes: Thousands of anecdotal reports suggest improved breathing, reduced mucus, and better quality of life.
Low cost and accessibility:
If proven effective, DMSO could democratize COPD care globally.
What You Can Do
If you’re serious about pushing this forward, here’s how to seed traction:
Petition for independent trials through university research centers or cooperative health networks.
Document patient outcomes in a structured format, symptom tracking, spirometry, dosage, and side effects.
Frame the inquiry as civic calibration, not fringe advocacy. This isn’t about miracle cures,it’s about refusing institutional drift and demanding auditability.
https://x.com/pat11060/status/1970036860953976955
Paul A. Szypula @Bubblebathgirl - Video: Mayor-elect Spiro Cheriogotis: “Bar is open you all go have fun!”
He just beat Kamala Harris-backed Barbara Drummond in Mobile, Alabama.
Another big win for MAGA!
>>/23647066/ pb
https://x.com/Bubblebathgirl/status/1970669025643635035
40